Rating History for Cellectis (CLLS) by Barclays
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/16/2026 | Lukas Shumway | Downgrade | Underweight (Overweight) |
1.30 (9.00) |
1.83 (1.04) |
-43.17% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/16/2026 | Lukas Shumway | Downgrade | Underweight (Overweight) |
1.30 (9.00) |
1.83 (1.04) |
-43.17% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||